Literature DB >> 21726665

Three new loci for determining x chromosome inactivation patterns.

Birgitte Bertelsen1, Zeynep Tümer, Kirstine Ravn.   

Abstract

The analysis of X chromosome inactivation (XCI) patterns is a widely used diagnostic tool in clinical practice when investigating X-linked diseases. The most commonly used assay to determine XCI patterns takes advantage of a locus within the androgen receptor (AR) gene. This PCR-based assay relies on two differentially methylated restriction enzyme sites (HpaII) and a polymorphic repeat located within this locus. Although highly informative, this locus is not always sufficient to evaluate the X-inactivation status in X-linked disorders. We have identified three new loci that can be used to determine XCI patterns in a methylation-sensitive PCR-based assay. All three loci contain polymorphic repeats and a methylation-sensitive restriction enzyme (HpaII) site, methylation of which was shown to correlate with XCI. DNA from 60 females was used to estimate the heterozygosity of these new loci. The reliability of the loci was validated by showing a high correlation between the results obtained by employing the new loci and the AR locus using DNA from 15 females who were informative for all four loci. Altogether, we show that these loci can be applied easily in molecular diagnostic laboratories, either as a supplement or as an alternative to the existing AR assay.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726665      PMCID: PMC3157618          DOI: 10.1016/j.jmoldx.2011.05.003

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  15 in total

Review 1.  X-inactivation and the dynamic maintenance of gene silencing.

Authors:  Jennifer L Salstrom
Journal:  Mol Genet Metab       Date:  2007-07-02       Impact factor: 4.797

2.  Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups.

Authors:  A Edwards; H A Hammond; L Jin; C T Caskey; R Chakraborty
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

3.  Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.

Authors:  D G Gilliland; K L Blanchard; J Levy; S Perrin; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

4.  Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene.

Authors:  I Redonnet-Vernhet; J K Ploos van Amstel; R P Jansen; R A Wevers; R Salvayre; T Levade
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

Review 5.  NEMO, NFkappaB signaling and incontinentia pigmenti.

Authors:  David L Nelson
Journal:  Curr Opin Genet Dev       Date:  2006-05-02       Impact factor: 5.578

6.  Clonal determination by the fragile X (FMR1) and phosphoglycerate kinase (PGK) genes in hematological malignancies.

Authors:  S T Lee; R C McGlennen; C E Litz
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

7.  Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age.

Authors:  L Busque; R Mio; J Mattioli; E Brais; N Blais; Y Lalonde; M Maragh; D G Gilliland
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

8.  Skewed X-chromosome inactivation is common in fetuses or newborns associated with confined placental mosaicism.

Authors:  A W Lau; C J Brown; M Peñaherrera; S Langlois; D K Kalousek; W P Robinson
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

9.  An X chromosome inactivation assay based on differential methylation of a CpG island coupled to a VNTR polymorphism at the 5' end of the monoamine oxidase A gene.

Authors:  R W Hendriks; Z Y Chen; H Hinds; R K Schuurman; I W Craig
Journal:  Hum Mol Genet       Date:  1992-06       Impact factor: 6.150

10.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

Authors:  R C Allen; H Y Zoghbi; A B Moseley; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

View more
  15 in total

1.  Progressive B Cell Loss in Revertant X-SCID.

Authors:  Connie H Lin; Hye Sun Kuehn; Timothy J Thauland; Christine M Lee; Suk See De Ravin; Harry L Malech; Timothy J Keyes; Astraea Jager; Kara L Davis; Maria I Garcia-Lloret; Sergio D Rosenzweig; Manish J Butte
Journal:  J Clin Immunol       Date:  2020-07-17       Impact factor: 8.317

2.  Identification of Intellectual Disability Genes in Female Patients with a Skewed X-Inactivation Pattern.

Authors:  Nathalie Fieremans; Hilde Van Esch; Maureen Holvoet; Gert Van Goethem; Koenraad Devriendt; Monica Rosello; Sonia Mayo; Francisco Martinez; Shalini Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Joris R Vermeesch; Peter Marynen; Guy Froyen
Journal:  Hum Mutat       Date:  2016-05-25       Impact factor: 4.878

Review 3.  X-linked sideroblastic anaemia in a female fetus: a case report and a literature review.

Authors:  Diane Nzelu; Panicos Shangaris; Lisa Story; Frances Smith; Chinthika Piyasena; Jayanthi Alamelu; Amira Elmakky; Maria Pelidis; Rachel Mayhew; Srividhya Sankaran
Journal:  BMC Med Genomics       Date:  2021-12-20       Impact factor: 3.063

4.  Otopalatodigital spectrum disorders: refinement of the phenotypic and mutational spectrum.

Authors:  Sébastien Moutton; Patricia Fergelot; Sophie Naudion; Marie-Pierre Cordier; Guilhem Solé; Elodie Guerineau; Christophe Hubert; Caroline Rooryck; Marie-Laure Vuillaume; Nada Houcinat; Julie Deforges; Julie Bouron; Sylvie Devès; Martine Le Merrer; Albert David; David Geneviève; Fabienne Giuliano; Hubert Journel; André Megarbane; Laurence Faivre; Nicolas Chassaing; Christine Francannet; Elisabeth Sarrazin; Eva-Lena Stattin; Jacqueline Vigneron; Danielle Leclair; Caroline Abadie; Pierre Sarda; Clarisse Baumann; Marie-Ange Delrue; Benoit Arveiler; Didier Lacombe; Cyril Goizet; Isabelle Coupry
Journal:  J Hum Genet       Date:  2016-05-19       Impact factor: 3.172

5.  Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1.

Authors:  Keiko Yamamoto-Shimojima; Taichi Imaizumi; Yusuke Aoki; Ken Inoue; Tadashi Kaname; Yusuke Okuno; Hideki Muramatsu; Kohji Kato; Toshiyuki Yamamoto
Journal:  J Hum Genet       Date:  2019-04-19       Impact factor: 3.172

6.  Methylation status of genes escaping from X-chromosome inactivation in patients with X-chromosome rearrangements.

Authors:  Sayaka Kawashima; Atsushi Hattori; Erina Suzuki; Keiko Matsubara; Machiko Toki; Rika Kosaki; Yukihiro Hasegawa; Kazuhiko Nakabayashi; Maki Fukami; Masayo Kagami
Journal:  Clin Epigenetics       Date:  2021-06-30       Impact factor: 6.551

7.  Insertion of an extra copy of Xq22.2 into 1p36 results in functional duplication of the PLP1 gene in a girl with classical Pelizaeus-Merzbacher disease.

Authors:  Julien Masliah-Planchon; Céline Dupont; George Vartzelis; Aurélien Trimouille; Eléonore Eymard-Pierre; Mathilde Gay-Bellile; Florence Renaldo; Imen Dorboz; Cécile Pagan; Samuel Quentin; Monique Elmaleh; Christina Kotsogianni; Elissavet Konstantelou; Séverine Drunat; Anne-Claude Tabet; Odile Boespflug-Tanguy
Journal:  BMC Med Genet       Date:  2015-09-02       Impact factor: 2.103

8.  Buccal swab as a reliable predictor for X inactivation ratio in inaccessible tissues.

Authors:  Bas de Hoon; Kim Monkhorst; Peter Riegman; Joop S E Laven; Joost Gribnau
Journal:  J Med Genet       Date:  2015-07-28       Impact factor: 6.318

9.  5meCpG epigenetic marks neighboring a primate-conserved core promoter short tandem repeat indicate X-chromosome inactivation.

Authors:  Filipe Brum Machado; Fabricio Brum Machado; Milena Amendro Faria; Viviane Lamim Lovatel; Antonio Francisco Alves da Silva; Claudia Pamela Radic; Carlos Daniel De Brasi; Álvaro Fabricio Lopes Rios; Susana Marina Chuva de Sousa Lopes; Leonardo Serafim da Silveira; Carlos Ramon Ruiz-Miranda; Ester Silveira Ramos; Enrique Medina-Acosta
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

10.  Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers.

Authors:  Marco Savarese; Olimpia Musumeci; Teresa Giugliano; Anna Rubegni; Chiara Fiorillo; Fabiana Fattori; Annalaura Torella; Roberta Battini; Carmelo Rodolico; Aniello Pugliese; Giulio Piluso; Lorenzo Maggi; Adele D'Amico; Claudio Bruno; Enrico Bertini; Filippo Maria Santorelli; Marina Mora; Antonio Toscano; Carlo Minetti; Vincenzo Nigro
Journal:  Neuromuscul Disord       Date:  2016-02-17       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.